These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25575113)

  • 1. How to explain recent multiple reports on the decline of inflammatory bowel disease in Canada.
    Qin X
    Can J Gastroenterol Hepatol; 2014 Dec; 28(11):620. PubMed ID: 25575113
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of dietary chemicals on gut bacteria and IBD demands further study.
    Qin X
    J Crohns Colitis; 2011 Apr; 5(2):175. PubMed ID: 21453893
    [No Abstract]   [Full Text] [Related]  

  • 3. When and how was the new round of increase in inflammatory bowel disease in the United States started?
    Qin X
    J Clin Gastroenterol; 2014 Jul; 48(6):564-5. PubMed ID: 24231936
    [No Abstract]   [Full Text] [Related]  

  • 4. May artificial sweeteners not sugar be the culprit of dramatic increase of inflammatory bowel disease in China?
    Qin X
    Chin Med J (Engl); 2014; 127(17):3196-7. PubMed ID: 25189972
    [No Abstract]   [Full Text] [Related]  

  • 5. What caused the recent worldwide increase of inflammatory bowel disease: should sucralose be added as a suspect?
    Qin X
    Inflamm Bowel Dis; 2011 Oct; 17(10):E139. PubMed ID: 21739539
    [No Abstract]   [Full Text] [Related]  

  • 6. Estimating the economic burden of inflammatory bowel disease in Canada: physician office visits and mesalamine prescriptions dispensed as surrogate markers.
    Wong VK; Lee TK; Yoshida EM
    Am J Gastroenterol; 2007 Nov; 102(11):2602-3; author reply 2603-4. PubMed ID: 17958766
    [No Abstract]   [Full Text] [Related]  

  • 7. Trends in Epidemiology of Pediatric Inflammatory Bowel Disease in Canada: Distributed Network Analysis of Multiple Population-Based Provincial Health Administrative Databases.
    Benchimol EI; Bernstein CN; Bitton A; Carroll MW; Singh H; Otley AR; Vutcovici M; El-Matary W; Nguyen GC; Griffiths AM; Mack DR; Jacobson K; Mojaverian N; Tanyingoh D; Cui Y; Nugent ZJ; Coulombe J; Targownik LE; Jones JL; Leddin D; Murthy SK; Kaplan GG
    Am J Gastroenterol; 2017 Jul; 112(7):1120-1134. PubMed ID: 28417994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidemiology of inflammatory bowel disease in Canada: a population-based study.
    Bernstein CN; Wajda A; Svenson LW; MacKenzie A; Koehoorn M; Jackson M; Fedorak R; Israel D; Blanchard JF
    Am J Gastroenterol; 2006 Jul; 101(7):1559-68. PubMed ID: 16863561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory bowel disease events after exposure to interleukin 17 inhibitors secukinumab and ixekizumab: Postmarketing analysis from the RADAR ("Research on Adverse Drug events And Reports") program.
    Orrell KA; Murphrey M; Kelm RC; Lee HH; Pease DR; Laumann AE; West DP; Nardone B
    J Am Acad Dermatol; 2018 Oct; 79(4):777-778. PubMed ID: 29920313
    [No Abstract]   [Full Text] [Related]  

  • 10. Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study.
    Abrahami D; Douros A; Yin H; Yu OHY; Renoux C; Bitton A; Azoulay L
    BMJ; 2018 Mar; 360():k872. PubMed ID: 29563098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases.
    Levine A; Sigall Boneh R; Wine E
    Gut; 2018 Sep; 67(9):1726-1738. PubMed ID: 29777041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of inflammatory bowel disease in four patients with juvenile idiopathic arthritis receiving etanercept or infliximab.
    Tarkiainen M; Tynjälä P; Vähäsalo P; Lahdenne P
    Scand J Rheumatol; 2011 Mar; 40(2):150-2. PubMed ID: 20868307
    [No Abstract]   [Full Text] [Related]  

  • 13. Measles vaccine, inflammatory bowel disease and pervasive developmental disorder: is there cause for concern?
    Amin J; McIntyre PB; Heath TC
    Commun Dis Intell; 1998 Apr; 22(4):58-9. PubMed ID: 9616048
    [No Abstract]   [Full Text] [Related]  

  • 14. Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data.
    Benchimol EI; Guttmann A; Griffiths AM; Rabeneck L; Mack DR; Brill H; Howard J; Guan J; To T
    Gut; 2009 Nov; 58(11):1490-7. PubMed ID: 19651626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotics during childhood and inflammatory bowel disease?
    Prescrire Int; 2014 Oct; 23(153):238-9. PubMed ID: 25964968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic use and inflammatory bowel diseases in childhood.
    Hviid A; Svanström H; Frisch M
    Gut; 2011 Jan; 60(1):49-54. PubMed ID: 20966024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease.
    Shaw SY; Blanchard JF; Bernstein CN
    Am J Gastroenterol; 2010 Dec; 105(12):2687-92. PubMed ID: 20940708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of inflammatory bowel disease in Québec: recent trends.
    Bitton A; Vutcovici M; Patenaude V; Sewitch M; Suissa S; Brassard P
    Inflamm Bowel Dis; 2014 Oct; 20(10):1770-6. PubMed ID: 25159452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing environmental risk factors affecting the inflammatory bowel diseases: a joint workshop of the Crohn's & Colitis Foundations of Canada and the USA.
    Bernstein CN
    Inflamm Bowel Dis; 2008 Aug; 14(8):1139-46. PubMed ID: 18521909
    [No Abstract]   [Full Text] [Related]  

  • 20. A national survey on the patterns of treatment of inflammatory bowel disease in Canada.
    Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
    BMC Gastroenterol; 2003 Jun; 3():10. PubMed ID: 12791168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.